Neurofibromatosis 2 Clinical Trials

• Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00445991 - Active, not recruiting
  Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition
  
• Trial to Evaluate the Safety of Lovastatin in Adults With Neurofibromatosis Type I (NF1)
  ClinicalTrials.gov Identifier: NCT00352599 - Recruiting
  Neurofibromatosis 1
  
• Pirfenidone in Children and Young Adults with Neurofibromatosis type I and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00076102 - Recruiting
  Neurofibromatosis 1; Neurofibroma, Plexiform
  
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00078936 - Recruiting
  neurofibromatosis 1 and 2 (NF1 and NF2)
  
• Quality of Friendships in Children With Neurofibromatosis
  ClinicalTrials.gov Identifier: NCT00508235 - Recruiting
  Neurofibromatosis
  
• NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
  ClinicalTrials.gov Identifier: NCT00169611 - Recruiting
  Neurofibromatosis Type 1
  
• R115777 to Treat Children with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00021541 - Recruiting
  Neurofibroma, Plexiform; Neurofibromatosis Type I
  
• Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00006435 - Active, not recruiting
  Neurofibroma, Plexiform; Neurofibromatosis Type I
  
• NF2 Natural History Consortium
  ClinicalTrials.gov Identifier: NCT00004483 - Active, not recruiting
  Schwannoma, Vestibular; Neurofibromatosis 2; Meningioma
  
• AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
  ClinicalTrials.gov Identifier: NCT00326872 - Recruiting
  Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition
  
• Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
  ClinicalTrials.gov Identifier: NCT00561665 - Recruiting
  Brain and Central Nervous System Tumors; Neurofibromatosis Type 1 (nf1); Neurofibromatosis Type 2 (nf2); Precancerous/Nonmalignant Condition
  
• Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
  ClinicalTrials.gov Identifier: NCT00060008 - Recruiting
  neurofibromatosis 1 and 2 (NF1 and NF2)
  
• Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00314119 - Recruiting
  Dermal Neurofibromas; Neurofibromatosis Type 1
  
• An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
  ClinicalTrials.gov Identifier: NCT00030043 - Completed
  Neurofibromatosis 2
  
• Pirfenidone to Treat Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00050453 - No longer recruiting
  Neurofibromatosis 1; Plexiform Neurofibroma
  
• Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
  ClinicalTrials.gov Identifier: NCT00303368 - Recruiting
  Neurofibromatosis Type 1; Tibial Dysplasia
  
• Variation in Gene Expression in Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00111384 - Recruiting
  
  
• Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
  ClinicalTrials.gov Identifier: NCT00004437 - Completed
  Neurofibromatosis 2
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
  ClinicalTrials.gov Identifier: NCT00304083 - Recruiting
  Neurofibromatosis Type 1 (nf1); Sarcoma
  
• Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00030264 - Recruiting
  childhood soft tissue sarcoma; childhood neurofibrosarcoma
  
• Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00029354 - Recruiting
  childhood neurofibrosarcoma; childhood soft tissue sarcoma
  
• Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinical Trial
  ClinicalTrials.gov Identifier: NCT00459199 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Leukemia; Long-Term Effects Secondary to Cancer Therapy in Adults; Long-Term Effects Secondary to Cancer Therapy in Children; Lymphoma; Neurofibromatosis Type 1 (nf1); Psychosocial Effects/Treatment; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00352495 - Suspended
  Brain and Central Nervous System Tumors; Neurofibromatosis Type 1 (nf1)
  
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00053937 - Completed
  childhood neurofibrosarcoma; childhood soft tissue sarcoma